post-thumb

Omega-3 deficiency may explain women’s risk of Alzheimer’s disease

  • 2 Min To Read
  • a year ago

Recent research has indicated that omega fatty acids may play a protective role against Alzheimer's disease in women. A study conducted by scientists from King's College London and Queen Mary University London, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, analyzed blood lipid levels in 841 participants, including those with Alzheimer's disease, mild cognitive impairment, and cognitively healthy controls.

The findings revealed a significant reduction in unsaturated fats, particularly omega fatty acids, in the blood of women diagnosed with Alzheimer's compared to their healthy counterparts. In contrast, no substantial differences in lipid composition were observed in men with Alzheimer's versus healthy men. This suggests that the role of lipids in Alzheimer's disease may vary by sex, which could help explain why women are diagnosed with the disease more frequently, particularly after the age of 80.

Dr. Cristina Legido-Quigley, the study's senior author, stated that the research underscores the need for further investigation into the lipid biology of Alzheimer's, particularly in women. The analysis utilized mass spectrometry to examine 700 different lipids, showing a marked increase in saturated (considered "unhealthy") lipids in women with Alzheimer's, alongside a notable decrease in omega fatty acids.

While the study provides statistical evidence suggesting a potential causal link between Alzheimer's disease and fatty acids, clinical trials are necessary to validate these findings. The researchers recommend that women ensure adequate omega fatty acid intake through diet or supplements, although further studies are needed to explore the implications of these dietary changes on Alzheimer's progression.

Dr. Julia Dudley from Alzheimer's Research UK emphasized the importance of understanding the mechanisms behind these gender differences, as this knowledge could inform tailored treatments and health advice in the future. The research received funding from LundbeckFonden and Alzheimer's Research UK.

Share: